Lv1
80 积分 2023-04-10 加入
Stapokibart Rapidly and Consistently Improves the Clinical Signs Across All Body Regions in Adults With Moderate‐to‐Severe Atopic Dermatitis
16天前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
16天前
已完结
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial
16天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
16天前
已完结
Overview of Biologics Targeting Type 2 Inflammation in Respiratory Disease
16天前
已完结
Practical Considerations for the Use of Antiemetics in Pregnant Patients With Breast Cancer
28天前
已关闭
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis
1个月前
已完结
Pregnancy outcomes in patients with MS following exposure to ofatumumab: Updated results (Novartis safety database)
1个月前
已关闭
Pregnancy and Multiple Sclerosis: A Narrative Review of Clinical Outcomes, Disease Activity, and Treatment Considerations
1个月前
已完结
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
1个月前
已完结
皖公网安备34019202002308
